JPS5934698B2 - Novel γ-trimethylammonium butyric acid methyl ester chloride monocrystal - Google Patents
Novel γ-trimethylammonium butyric acid methyl ester chloride monocrystalInfo
- Publication number
- JPS5934698B2 JPS5934698B2 JP51044308A JP4430876A JPS5934698B2 JP S5934698 B2 JPS5934698 B2 JP S5934698B2 JP 51044308 A JP51044308 A JP 51044308A JP 4430876 A JP4430876 A JP 4430876A JP S5934698 B2 JPS5934698 B2 JP S5934698B2
- Authority
- JP
- Japan
- Prior art keywords
- act
- novel
- water
- methyl ester
- acid methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は新規なγ一トリメチルアンモニウム酪酸メチル
エステルクロリド−水晶(以下ACT・H2Oと略す)
に関する。Detailed Description of the Invention The present invention provides a novel γ-trimethylammonium butyric acid methyl ester chloride crystal (hereinafter abbreviated as ACT・H2O).
Regarding.
ACTは胃腸機能改善剤として又毛根機能賦活剤として
有用な医薬品であり、物理的性状として水、メタノール
、エタノール、ジメチルホルムアミドに易溶であり、特
に水に対する溶解度は非常に大きいこと(ACT19は
約0.39の水に室温で溶解)及びアセトン、酢酸エチ
ル、エーテル等に難溶であることが知られている。ACT is a drug useful as a gastrointestinal function improving agent and a hair root function activator, and its physical properties include that it is easily soluble in water, methanol, ethanol, and dimethylformamide, and its solubility in water is particularly high (ACT19 is approximately It is known to be slightly soluble in acetone, ethyl acetate, ether, etc.).
従つて、種々の製造法によつて得られた最終反応混合物
より純粋なACTを単離する場合には従来アセトン(特
公昭37−17961号公報参照)、メタノール−アセ
トン又はジメチルホルムアミド−アセトンの混合溶媒(
特開昭48−5714号公報参照)を使用し晶析させる
方法が好ましいものとして採用されてきた。しかしなが
ら、かかる溶媒を使用してACTを晶析させた場合には
、ACTの晶析率が低いこと、不純物の除去が十分でな
いこと、得られた結晶が吸湿性が高く取り扱いが困難な
こと等工業土好ましからざる欠陥を有していた。Therefore, when isolating pure ACT from the final reaction mixture obtained by various production methods, conventionally a mixture of acetone (see Japanese Patent Publication No. 37-17961), methanol-acetone or dimethylformamide-acetone is used. solvent(
A method of crystallization using JP-A No. 48-5714) has been adopted as a preferred method. However, when ACT is crystallized using such a solvent, the crystallization rate of ACT is low, impurities are not sufficiently removed, and the obtained crystals are highly hygroscopic and difficult to handle. Industrial soil had undesirable defects.
本発明者等はかかる工業上の欠陥を克服するため鋭意検
討を試みた結果、不純物を包含するACTを含水有機溶
媒で処理すると従来のACTとは全く異なる物理的性状
を有する結晶が得られること、この結晶は従来の有機溶
媒から晶析させて得られたACTそのもの、即ち、無水
物とは異なり、一分子の結晶水が結合した新規なACT
含水晶であることを熱分析、IRスペクトル等で確認し
た。The present inventors have made intensive studies to overcome these industrial deficiencies and have found that when ACT containing impurities is treated with a water-containing organic solvent, crystals with physical properties completely different from those of conventional ACT can be obtained. , this crystal is ACT itself obtained by crystallizing from a conventional organic solvent, that is, unlike anhydride, it is a new ACT with one molecule of crystal water bound to it.
It was confirmed by thermal analysis, IR spectrum, etc. that it was a quartz-containing crystal.
添付第1図はACT−H2Oの示差熱分析曲線図を示し
、分析条件は下表の通りである。Attached FIG. 1 shows a differential thermal analysis curve diagram of ACT-H2O, and the analysis conditions are as shown in the table below.
ACTの一水晶と無水晶と物理的性状の相異は下記の如
く要約される。The differences in physical properties between monoquartz and aquartz ACT are summarized as follows.
LJ)P]ゴυvν
(8)アセトン−メタノール(95:5)混合溶媒に対
する溶解度(無水物換算の溶質/溶液重量%)上記デー
ターからも明らかな如く、ACT−H2Oは無水晶と特
異的に異なり、ACT−H2Oの有機溶媒に対する溶解
度特に最も工業的に有利であるアセトン−メタノール混
合溶媒に対し無水晶の場】. 1合の一〜−であるこ
と、従つて、良好な晶析率をもつて目的物を取得しうる
ことを見い出した。LJ) P]goυvν (8) Solubility in acetone-methanol (95:5) mixed solvent (solute/solution weight % in terms of anhydride) As is clear from the above data, ACT-H2O is uniquely different from anhydrous crystals. In contrast, the solubility of ACT-H2O in organic solvents is different from that of acetone-methanol mixed solvent, which is the most industrially advantageous. It has been found that the ratio is 1 to -1, and therefore, the desired product can be obtained with a good crystallization rate.
即ち、ACTは前記した如く水に対する溶解度が非常に
大きくかつ吸湿性が大であることから常識的には含水溶
媒からの晶析は晶析率を低下せしめると考えられるのに
対し、全く相反する驚くべき事実を見い出したのである
。更には又、かくして得られたACT・H2Oは無水晶
に比べ格段の低吸湿性を有すること、従つて製品として
の取扱いの容易性を具備したものであり、商品としての
価値の高いものであることを見い出したものである。That is, as mentioned above, ACT has extremely high solubility in water and high hygroscopicity, so common sense would suggest that crystallization from a water-containing solvent would reduce the crystallization rate, but this is completely contradictory. He discovered a surprising fact. Furthermore, the ACT/H2O obtained in this way has a significantly lower hygroscopicity than quartz-free crystals, and is therefore easy to handle as a product, making it highly valuable as a commercial product. This is what I discovered.
以上の知見をもとに本発明者等はACTを晶析させる工
程に於ては含水有機溶媒を使用して新規なACT−H2
O結晶として晶析させることが極めて工業上有利である
ことを見い出し、更に詳細な晶析条件を検討し下記の結
果をえた。Based on the above knowledge, the present inventors used a water-containing organic solvent in the process of crystallizing ACT to create a novel ACT-H2.
It was found that crystallizing as O crystals is extremely advantageous industrially, and more detailed crystallization conditions were studied and the following results were obtained.
ACT−H2Oの晶析率はACTに対し1.0〜1.5
モル倍の水を加えた含水有機溶媒が最も高く、不純物の
除去率は水分含量が高くなる程上昇する。工業的に有利
な晶析条件としては不純物の含有量により異なるがAC
Tに対し1〜2モル倍の水を加えた含水有機溶媒が好ま
しいといえる。かくする場合、不純物の除去も従来の無
水晶として晶析させる場合に比べ、はるかに良好な結果
を与える。The crystallization rate of ACT-H2O is 1.0 to 1.5 relative to ACT
A water-containing organic solvent to which twice the molar amount of water is added has the highest impurity removal rate, and the removal rate of impurities increases as the water content increases. Industrially advantageous crystallization conditions vary depending on the content of impurities, but AC
It can be said that a water-containing organic solvent in which water is added in an amount of 1 to 2 moles relative to T is preferable. In this case, the removal of impurities also gives much better results than in the case of conventional crystallization as an aquartz crystal.
例えば不純物含量1.0%のACTlOOgを水一メタ
ノールーアセトン(10m1:15m1:300Tt1
)の混合溶媒で処理した場合、得られた結晶中の不純物
含量は0.2〜0.3%迄低下するのに反し、メタノー
ル−アセトン(15m1:300m1)の混合溶媒で処
理した場合には得られた結晶中の不純物含量は0.7〜
0.8%と不純物除去効果は極めて小さいものである。
以上の如く本願発明は含水有機溶媒で処理することによ
り吸湿性の弱い新規なACT−H2Oを高純度高収率で
製する方法を提供したものである。For example, ACTlOOg with an impurity content of 1.0% is mixed with water, methanol, acetone (10ml:15ml:300Tt1).
), the impurity content in the obtained crystals decreased to 0.2-0.3%, whereas when treated with a mixed solvent of methanol-acetone (15ml:300ml), The impurity content in the obtained crystals is 0.7~
At 0.8%, the impurity removal effect is extremely small.
As described above, the present invention provides a method for producing a novel ACT-H2O with low hygroscopicity with high purity and high yield by treatment with a water-containing organic solvent.
以下実施例を挙げて本発明を説明する。実施例 】
ACT(無水物)1009を水10m11メタノール2
5m1に加温溶解し、アセトン500m1を加え、5〜
10℃で2時間撹拌し析出結晶を濾取。The present invention will be explained below with reference to Examples. Example] ACT (anhydride) 1009 in water 10ml 11 methanol 2
Dissolve in 5 ml by heating, add 500 ml of acetone, and
The mixture was stirred at 10°C for 2 hours and the precipitated crystals were collected by filtration.
40〜50℃,10〜20mmHgで3時間乾燥。Dry for 3 hours at 40-50°C and 10-20 mmHg.
収量92.89(水分含量8.4%)。本結晶は10m
mHg以下75〜85℃で8時間乾燥する事により水分
含量0.1%以下となる。Yield: 92.89 (moisture content: 8.4%). This crystal is 10m
By drying for 8 hours at 75 to 85°C below mHg, the water content becomes 0.1% or less.
実施例 2ACT(無水物)1009を水10m1およ
びアミールアルコール150m1に加温溶解し、活性炭
処理後5〜10℃で2時間攪拌し析出結晶を濾取。Example 2 ACT (anhydride) 1009 was heated and dissolved in 10 ml of water and 150 ml of amyl alcohol, treated with activated carbon, stirred at 5 to 10°C for 2 hours, and precipitated crystals were collected by filtration.
40〜50℃,10〜20mmHgで4時間乾燥。Dry for 4 hours at 40-50°C and 10-20 mmHg.
収量89.59(水分含量8.4%)。Yield: 89.59 (moisture content: 8.4%).
第1図はACT−H2Oの示差熱分析曲線図である。 FIG. 1 is a differential thermal analysis curve diagram of ACT-H2O.
Claims (1)
ロリド一水晶。1 γ-trimethylammonium butyric acid methyl ester chloride monocrystal.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP51044308A JPS5934698B2 (en) | 1976-04-19 | 1976-04-19 | Novel γ-trimethylammonium butyric acid methyl ester chloride monocrystal |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP51044308A JPS5934698B2 (en) | 1976-04-19 | 1976-04-19 | Novel γ-trimethylammonium butyric acid methyl ester chloride monocrystal |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS52128320A JPS52128320A (en) | 1977-10-27 |
| JPS5934698B2 true JPS5934698B2 (en) | 1984-08-24 |
Family
ID=12687854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51044308A Expired JPS5934698B2 (en) | 1976-04-19 | 1976-04-19 | Novel γ-trimethylammonium butyric acid methyl ester chloride monocrystal |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5934698B2 (en) |
-
1976
- 1976-04-19 JP JP51044308A patent/JPS5934698B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS52128320A (en) | 1977-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6829304B2 (en) | Improved process for the preparation of Sugamadex | |
| JPS61293949A (en) | Optical resolution of alpha-isopropyl-p-chlorophenylacetic acid | |
| US4061676A (en) | Recovery of doxycycline and products thereof | |
| US4219641A (en) | Process for preparing erythromycin succinate | |
| JPS5934698B2 (en) | Novel γ-trimethylammonium butyric acid methyl ester chloride monocrystal | |
| JPH07508495A (en) | Oxytetracycline purification method and intermediates | |
| JPS62242692A (en) | Production of moranoline derivative | |
| US2421142A (en) | Process for obtaining crystalline riboflavin | |
| JPS5945668B2 (en) | Novel method for producing (3-carbomethoxypropyl)-trimethylammonium chloride hydrate | |
| JPH01153654A (en) | Production of ammonium fluorine-containing carboxylate | |
| JPH0796537B2 (en) | Method for purifying 3- (3,4-dihydroxyphenyl) serine | |
| KR100325558B1 (en) | Method for Purifying 7-chloroquinoline-8-carboxylic Acid | |
| JPS6210930B2 (en) | ||
| JP3815064B2 (en) | Method for purifying 1- (4-chlorobenzoyl) -5-methoxy-2-methylindole-3-acetic acid | |
| JPS593476B2 (en) | Optically active chlorpheniramine/acylphenylglycine salt and method for producing the same | |
| US4370485A (en) | Germaazaspirodiones | |
| US2013731A (en) | Process for producing salts of acetyl-choline | |
| JPH05222041A (en) | Purification method of adenine derivative | |
| JPH0739410B2 (en) | Novel method for producing 6- (3-dimethylaminopropionyl) forskolin | |
| JPS61172846A (en) | Method of optical resolution of (+-)-2-chloroprorionic acid | |
| JPS5849556B2 (en) | 3-Hydroxyphthalide | |
| JP2571939B2 (en) | Cyclopentenone derivatives and their production | |
| JP2782897B2 (en) | Purification method of alkali metal alcoholate | |
| JPH069523A (en) | Method for purifying 4-dedimethylaminotetracycline | |
| JPS59443B2 (en) | Purification method of anhydrous sodium dithionite |